Donoghue Forlines’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-959
| Closed | -$236K | – | 278 |
|
|
2022
Q3 | $236K | Sell |
959
-1,556
| -62% | -$383K | 0.09% | 202 |
|
|
2022
Q2 | $622K | Sell |
2,515
-288
| -10% | -$71.2K | 0.16% | 170 |
|
|
2022
Q1 | $928K | Buy |
2,803
+816
| +41% | +$270K | 0.2% | 149 |
|
|
2021
Q4 | $714K | Buy |
1,987
+444
| +29% | +$160K | 0.12% | 188 |
|
|
2021
Q3 | $502K | Buy |
+1,543
| New | +$502K | 0.1% | 186 |
|
|
2021
Q1 | – | Sell |
-2,466
| Closed | -$799K | – | 318 |
|
|
2020
Q4 | $799K | Sell |
2,466
-2,557
| -51% | -$828K | 0.15% | 169 |
|
|
2020
Q3 | $1.39M | Buy |
+5,023
| New | +$1.39M | 0.38% | 46 |
|
|
2018
Q3 | – | Sell |
-5,388
| Closed | -$2.2M | – | 200 |
|
|
2018
Q2 | $2.2M | Buy |
+5,388
| New | +$2.2M | 0.18% | 92 |
|